In May 2009, and after years of anticipation, the U.S. FDA finally approved Dysport® for cosmetic use. Dysport® is now the only competitor to Botox® cosmetic in the United States. Dysport® has been successfully used in Europe and the Americas for over 15 years, and has a proven track record of safety and success in the United Kingdom, Germany, and many other European countries. Like Botox®, Dysport® is administered via injections at the site of wrinkles and acts by temporarily weakening the facial muscles, which then smooth and soften the facial wrinkles and lines caused by excessive action of these muscles. The result is a face that looks fresher and younger.
Dysport® is made from the same active ingredient as Botox® (made by Allergan), Clostridium botulinum toxin type A. However, the manufacturing process of Dysport® is slightly different, resulting in slight differences in its clinical use for cosmetic purposes. For instance, Dysport may provide a little faster onset of action and has a greater 'spread' (giving a more 'natural' look) compared to BOTOX®. Botox®, on the other hand, tends to remain more localized, allowing for greater precision in the treatment area, but possibly requiring more injections in the course of a treatment. There are also claims and suggestions that Dysport® results might last up to a month or even two beyond that of Botox®. The unit dosage of each product is also different and accordingly different number of units have to be used to achieve comparable results.
Dr. DeLisi has worked with both products and is fully comfortable using either product to his patient's benefit. Having alternative products to choose from is always beneficial for patients, as it enables the physician to choose the best treatment according to each patient's individual needs, previous responses to treatment, and patient expectations.
Please CALL TODAY to schedule your personal consultation and find out if Dysport is right for you.